Tafenoquine receives regulatory approval in USA for prophylaxis of malaria and radical cure of Plasmodium vivax
Author(s) -
Kathrine R. Tan,
Jimee Hwang
Publication year - 2018
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1093/jtm/tay071
Subject(s) - medicine , plasmodium vivax , malaria , malaria prophylaxis , primaquine , drug approval , intensive care medicine , plasmodium falciparum , immunology , pharmacology , chloroquine , drug
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom